General Information
Revision date
2013-07-09
Product name
Mustargen
Chemical name
HOW SUPPLIED: 100 mg Vials for Intravenous Use
1.2.1 Relevant identified uses
Antineoplastic Pharmaceutical for Human Use
supplier name
RECORDATI RARE DISEASES INC
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
RECORDATI RARE DISEASES INC
e-mail address of the competent person responsible for the Safety Data Sheet
info@recordatirarediseases.com
Section 2
SECTION 2: Hazards identification
Directive 67/548/EEC: EU LABELING/CLASSIFICATION: This product meets the definitions of Carcinogenic Category 2, Mutagenic Category 2, Toxic for Reproduction Category 2, Very Toxic, and Irritant, as defined by the European Union Council Directive 67/548/EEC and subsequent directives. (See Section 15 for details on classification) Carcinogenic Category 2; Mutagenic Category 2; Toxic for Reproduction Category 2; Very Toxic; Irritant
Hazard statements
[R 26/28]; [R 36/38]; [R 45]; [R 46]; [R 48]; [R 61] EMERGENCY OVERVIEW
Product definition
This product is supplied as a light yellow-brown crystalline powder with a faint, fishy odor
Health hazards
This product is a cytotoxic antineoplastic agent. This product can cause cancer, reduced fertility and reproductive effects in both men and women, and birth defects. This product may be fatal if swallowed or inhaled. Contact can severely irritate the eyes, skin, and respiratory system. Flammability Hazards: When involved in a fire, this material may decompose and produce irritating vapors and toxic compounds (including e.g., carbon oxides, nitrogen oxides, and hydrogen chloride). Reactivity Hazards: This product is not reactive.
Environmental hazards
This product may be harmful if released into aquatic and terrestrial environments Emergency Considerations: Emergency responders should wear Level A protection appropriate for highly toxic or potent compounds.
